A subset of C9orf72 repeat expansion-carrying frontotemporal dementia patients display an Alzheimer-like decrease in cerebrospinal fluid amyloid-β (Aβ) biomarker levels. We report that downregulation of C9orf72 in non-neuronal human cells overexpressing amyloid-β protein precursor (AβPP) resulted in increased levels of secreted AβPP fragments and Aβ, while levels of AβPP or its C-terminal fragments (CTFs) remained unchanged. In neuronal cells, AβPP and C83 CTF levels were decreased upon C9orf72 knockdown, but those of secreted AβPP fragments or Aβ remained unchanged. C9orf72 protein levels significantly increased in human brain with advancing neurofibrillary pathology and positively correlated with brain Aβ42 levels. Our data suggest that altered C9orf72 levels may lead to cell-type specific alterations in AβPP processing, but warrant further studies to clarify the underlying mechanisms.
LevineTP, DanielsRD, GattaAT, WongLH, HayesMJ (2013) The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics29, 499–503.
10.
ZhangD, IyerLM, HeF, AravindL (2012) Discovery of novel DENN proteins: Implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front Genet3, 283.
XiaoS, MacNairL, McGoldrickP, McKeeverPM, McLeanJR, ZhangM, KeithJ, ZinmanL, RogaevaE, RobertsonJ (2015) Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann Neurol78, 568–583.
13.
BeckJ, PoulterM, HensmanD, RohrerJD, MahoneyCJ, AdamsonG, CampbellT, UphillJ, BorgA, FrattaP, OrrellRW, MalaspinaA, RoweJ, BrownJ, HodgesJ, SidleK, PolkeJM, HouldenH, SchottJM, FoxNC, RossorMN, TabriziSJ, IsaacsAM, HardyJ, WarrenJD, CollingeJ, MeadS (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet92, 345–353.
DavidsonYS, RobinsonAC, SnowdenJS, MannDM (2013) Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer’s disease. Acta Neuropathol Commun1, 5059601–50.
HerukkaSK, HallikainenM, SoininenH, PirttilaT (2005) CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. Neurology64, 1294–1297.
18.
TapiolaT, AlafuzoffI, HerukkaSK, ParkkinenL, HartikainenP, SoininenH, PirttilaT (2009) Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol66, 382–389.
19.
KamalainenA, HerukkaSK, HartikainenP, HelisalmiS, MoilanenV, KnuuttilaA, JanssonL, TienariPJ, RemesAM (2015) Cerebrospinal fluid biomarkers for Alzheimer’s disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion. Dement Geriatr Cogn Disord39, 287–293.
20.
LichtenthalerSF, DominguezDI, WestmeyerGG, ReissK, HaassC, SaftigP, De StrooperB, SeedB (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem278, 48713–48719.
NatunenT, TakaloM, KemppainenS, LeskelaS, MarttinenM, KurkinenKM, PursiheimoJP, SarajarviT, ViswanathanJ, GabboujS, SoljeE, TahvanainenE, PirttimakiT, KurkiM, PaananenJ, RauramaaT, MiettinenP, MakinenP, LeinonenV, SoininenH, AirenneK, TanziRE, TanilaH, HaapasaloA, HiltunenM (2016) Relationship between ubiquilin-1 and BACE1 in human Alzheimer’s disease and APdE9 transgenic mouse brain and cell-based models. Neurobiol Dis85, 187–205.
23.
MartiskainenH, ViswanathanJ, NykanenNP, KurkiM, HelisalmiS, NatunenT, SarajarviT, KurkinenKM, PursiheimoJP, RauramaaT, AlafuzoffI, JaaskelainenJE, LeinonenV, SoininenH, HaapasaloA, HuttunenHJ, HiltunenM (2015) Transcriptomics and mechanistic elucidation of Alzheimer’s disease risk genes in the brain and in vitro models. Neurobiol Aging36, 1221.e15–1221.e28.
24.
BraakH, AlafuzoffI, ArzbergerT, KretzschmarH, Del TrediciK (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol112, 389–404.
25.
NatunenT, ParradoAR, HelisalmiS, PursiheimoJP, SarajarviT, MakinenP, KurkinenKM, MullinK, AlafuzoffI, HaapasaloA, BertramL, SoininenH, TanziRE, HiltunenM (2013) Elucidation of the BACE1 regulating factor GGA3 in Alzheimer’s disease. J Alzheimers Dis37, 217–232.
26.
BrittonD, ZenY, QuagliaA, SelzerS, MitraV, LobetanerC, JungS, BohmG, SchmidP, PrefotP, HoehleC, KoncarevicS, GeeJ, NicholsonR, WardM, CastellanoL, StebbingJ, ZuchtHD, SarkerD, HeatonN, PikeI (2014) Quantification of pancreatic cancer proteome and phosphorylome: Indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One9, e90948.
27.
KurkinenKM, MarttinenM, TurnerL, NatunenT, MakinenP, HaapalinnaF, SarajarviT, GabboujS, KurkiM, PaananenJ, KoivistoAM, RauramaaT, LeinonenV, TanilaH, SoininenH, LucasFR, HaapasaloA, HiltunenM (2016) SEPT8 modulates beta-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1. J Cell Sci129, 2224–2238.
28.
WaiteAJ, BaumerD, EastS, NealJ, MorrisHR, AnsorgeO, BlakeDJ (2014) Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging35, 1779.e5–1779.e13.
29.
ThinakaranG, KooEH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem283, 29615–29619.
30.
HiltunenM, van GroenT, JolkkonenJ (2009) Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: Evidence from experimental studies. J Alzheimers Dis18, 401–412.
31.
FolR, BraudeauJ, LudewigS, AbelT, WeyerSW, RoedererJP, BrodF, AudrainM, BemelmansAP, BuchholzCJ, KorteM, CartierN, MullerUC (2016) Viral gene transfer of APPsalpha rescues synaptic failure in an Alzheimer’s disease mouse model. Acta Neuropathol131, 247–266.
32.
JiangS, LiY, ZhangX, BuG, XuH, ZhangYW (2014) Trafficking regulation of proteins in Alzheimer’s disease. Mol Neurodegener9, 613269–6.
33.
VassarR, BennettBD, Babu-KhanS, KahnS, MendiazEA, DenisP, TeplowDB, RossS, AmaranteP, LoeloffR, LuoY, FisherS, FullerJ, EdensonS, LileJ, JarosinskiMA, BiereAL, CurranE, BurgessT, LouisJC, CollinsF, TreanorJ, RogersG, CitronM (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science286, 735–741.
